WHO 총회서 코로나19 치료제•백신의 공정한 유통 결의<br /><br />Our top story this morning.<br />Countries taking part in the WHO's annual assembly have agreed on the need for a transparent and fair access to vaccines and treatment against COVID-19, which has infected almost five million people globally.<br />They also endorsed a resolution tabled by the EU to start an independent probe into the WHO's response to the pandemic.<br />Kim Hyo-sun reports.<br />The 194 member states of the World Health Organization are calling for the need for transparent, equitable and timely access to any treatments or vaccines developed against COVID-19.<br />During the World Health Assembly meeting on Tuesday,...held virtually,... its members also agreed to launch an independent probe into the WHO's handling of the pandemic.<br />The agreement came as the European Union initiated a resolution calling for a comprehensive, impartial and independent assessment of the agency's response.<br />It was endorsed by nearly one-hundred member states.<br />Welcoming the resolution,... the WHO chief highlighted the principles of transparency and accountability.<br />"As always, WHO remains fully committed to transparency, accountability and continuous improvement. We want accountability more than anyone."<br />The resolution was supported by China and the U.S.,... who have been at odds over the WHO, following the Trump administration's threats to withdraw from the agency.<br />On the day of the meeting,... President Trump threatened to permanently halt funding for the WHO if it does not commit to improvements within 30 days.<br />Washington, however, was criticized by the EU for weakening multilateral cooperation and coordination in the face of a global crisis.<br />On the sidelines,... the issue of enabling Taiwan to attend the conference was also a hot topic.<br />In the run-up to the meeting,... calls for Taiwan to be allowed to join, led mainly by the U.S.,... threatened to anger Beijing, which has blocked Taiwan from attending since 2016, under its one-China policy.<br />Kim Hyo-sun, Arirang News.<br />
